×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 9: Special Topics for Clinical Research (Continued)
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
- Surrogate Endpoints
- Qualification of Drug Development Tools
- Foreign Clinical Trials
- Changes to the Investigational Drug
- Financial Disclosure by Clinical Investigators
Have an account?